Ibritumomab, known as Zevalin, represents the innovative form of specific radiotherapy employed to treat certain kinds of cancers, particularly recurring follicular lymphoma cases . This is an monoclonal molecule conjugated to yttrium-90 , the radioactive element that delivers precise radiation dire